Next generation sequencing has significantly improved definition of the immunoglobulin heavy chain variable region (IGHV) in patients with chronic lymphocytic leukaemia. Associate Professor Bryone Kuss, academic head of molecular medicine and pathology at Flinders Medical Centre and Flinders University, said that with next generation sequencing less than 2% of patients’ IGHV status remained undetermined. “With ...
Improvement in sequencing CLL provides prognostic indicator
By Mardi Chapman
4 Aug 2017